Osmosis Investment Management UK Ltd Buys Shares of 6,479 Corteva, Inc. $CTVA

Osmosis Investment Management UK Ltd purchased a new position in Corteva, Inc. (NYSE:CTVA) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 6,479 shares of the company’s stock, valued at approximately $549,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Compass Financial Management LLC bought a new position in shares of Corteva in the 2nd quarter worth $25,000. Elevation Wealth Partners LLC boosted its position in Corteva by 334.6% during the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after purchasing an additional 261 shares in the last quarter. Clearstead Trust LLC bought a new stake in Corteva during the second quarter valued at about $31,000. JPL Wealth Management LLC purchased a new position in Corteva in the third quarter valued at about $25,000. Finally, N.E.W. Advisory Services LLC bought a new position in Corteva in the second quarter worth about $33,000. 81.54% of the stock is currently owned by institutional investors.

Corteva Trading Up 0.4%

Shares of Corteva stock opened at $83.18 on Wednesday. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $90.97. The firm has a market capitalization of $55.50 billion, a price-to-earnings ratio of 55.09, a PEG ratio of 2.54 and a beta of 0.57. The firm’s 50 day simple moving average is $82.39 and its two-hundred day simple moving average is $80.37.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. During the same quarter last year, the company posted $2.20 earnings per share. The business’s quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Analysts predict that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be paid a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is 47.68%.

Analyst Upgrades and Downgrades

Several analysts have commented on CTVA shares. Morgan Stanley increased their price target on shares of Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. Rothschild & Co Redburn upped their price target on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $101.00 price objective on shares of Corteva in a report on Monday, August 3rd. Jefferies Financial Group boosted their target price on Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Finally, BNP Paribas Exane upped their target price on Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, Corteva currently has an average rating of “Moderate Buy” and an average price target of $91.50.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.